BridgeMD
New treatment option for Developmental Language Disorders
Official title Treating Complex Grammar Knowledge Deficits in School-Age Children With Developmental Language Disorder
ClinicalTrials.gov ID: NCT06911138
What this study is testing
- What it's testing
- The goal of this project is to compare the relative effectiveness of two novel treatments to improve the complex grammar knowledge of school-age (8-11-year-old) children with developmental language disorder (DLD). Treatment 1 is an implicit approach to promoting children's automatic grammar learning and Treatment 2 is a more conventional explicit approach in which participants are taught the rules underlying the grammar.
- Time commitment: about 10 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 11
You may be able to join if
- Language impairment: standard score of 34 or lower on the Test of Language and Learning Skills
- Nonverbal IQ: nonverbal quotient of 77 or higher
- Normal range hearing
- Normal or corrected vision
- Native English speaker
You likely can't join if
- Neurodevelopmental disorder
- Emotional/behavioral disorder
- Frank neurological disorder
- Treatment for complex syntax from outside clinician
See the full eligibility criteria
- Language impairment: standard score of 34 or lower on the Test of Language and Learning Skills
- Nonverbal IQ: nonverbal quotient of 77 or higher
- Normal range hearing
- Normal or corrected vision
- Native English speaker
- Sentence comprehension screening/sentence chunking screening 50% or lower
- Neurodevelopmental disorder
- Emotional/behavioral disorder
- Frank neurological disorder
- Treatment for complex syntax from outside clinician
The study team makes the final eligibility decision.
Where it's taking place
- Tucson, Arizona, United States
- Athens, Ohio, United States
- Logan, Utah, United States
- Morgantown, West Virginia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 10 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 11 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tucson, Arizona, United States; Athens, Ohio, United States; Logan, Utah, United States; Morgantown, West Virginia, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.